Advancing MSI Testing in Endometrial Cancer
May 14, 2026
Promega’s FDA-approved companion diagnostic aims to expand treatment pathways while fitting seamlessly into routine pathology workflows
7 min read
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False